Hint mode is switched on Switch off
For swift navigation between sections

Accelerate Diagnostics
LEI 2549007HE5QY1QEQ8K43

PDF download

Choose all Reset all
Download Cancel
The issuer's bonds defaulted in 2025
Organization name
Accelerate Diagnostics, Inc.
Country name
USA
Country of registration
USA
Industry
Miscellaneous Healthcare: Products and Services
Public debt
58 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States.

Awards

News

08/08/2025 Accelerate Diagnostics: Entry Into A Material Definitive Agreement, Bankruptcy Or Receivership, Completion Of Acquisition Or Disposition Of Assets, Financial Statements And Exhibits
25/06/2025 North American Morning Briefing: Oil Rises, Cease-Fire Appears to Hold; Powell To Resume Testimony
30/05/2025 Accelerate Diagnostics: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
08/05/2025 Accelerate Diagnostics: Entry Into A Material Definitive Agreement, Bankruptcy Or Receivership, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Triggering Events That Accelerate Or Increase A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
06/05/2025 Accelerate Diagnostics: Notice Of Delisting Or Failure To Satisfy A Continued Listing Ruleor Standard; Transfer Of Listing
All organization news

Documentation

IFRS/US GAAP reports

2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    2549007HE5QY1QEQ8K43
  • SIC
    3826 LABORATORY ANALYTICAL INSTRUMENTS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0000727207
  • EIN
    84-1072256
Registration is required to get access.